PKCε has also shown to facilitate hepatic steatosis and impairment of hepatic insulin signaling, thus, promoting insulin resistance which is a major factor in liver disease and development of HCC in patients with chronic HCV infection [15–17]. Here, INS is linked to hepatocellular carcinoma.